Cargando…

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus

BACKGROUND: SGLT‐2 (sodium glucose transporter‐2) inhibitors and GLP‐1RAs (glucagon‐like peptide‐1 receptor agonists) effectively lowered cardiovascular risk in large clinical trials for patients with type 2 diabetes mellitus at high risk for these complications, and have been recommended by guideli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nargesi, Arash A., Jeyashanmugaraja, Gini P., Desai, Nihar, Lipska, Kasia, Krumholz, Harlan, Khera, Rohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403287/ https://www.ncbi.nlm.nih.gov/pubmed/33998258 http://dx.doi.org/10.1161/JAHA.121.021084

Ejemplares similares

County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries
por: Hanna, Jonathan, et al.
Publicado: (2022)

Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States
por: Shen, Miles, et al.
Publicado: (2022)

Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020
por: Dhingra, Lovedeep S., et al.
Publicado: (2023)

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study
por: Khera, Rohan, et al.
Publicado: (2018)

Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018)

Sex and Race Differences in the Utilization and Outcomes of Coronary Artery Bypass Grafting Among Medicare Beneficiaries, 1999–2014
por: Angraal, Suveen, et al.
Publicado: (2018)

Association of Diabetes Mellitus With Health Status Outcomes in Young Women and Men After Acute Myocardial Infarction: Results From the VIRGO Study
por: Ding, Qinglan, et al.
Publicado: (2019)

Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States
por: Khera, Rohan, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Financial Barriers Among Overweight and Obese Adults Eligible for Semaglutide in the United States
por: Lu, Yuan, et al.
Publicado: (2022)

Automated Identification of Heart Failure with Reduced Ejection Fraction using Deep Learning-based Natural Language Processing
por: Nargesi, Arash A., et al.
Publicado: (2023)

Tropical Plant Extracts as Potential Antihyperglycemic Agents
por: Manaharan, Thamilvaani, et al.
Publicado: (2012)

An Evaluation of the Vulnerable Physician Workforce in the United States During the Coronavirus Disease-19 Pandemic
por: Khera, Rohan, et al.
Publicado: (2020)

An Evaluation of the Vulnerable Physician Workforce in the USA During the Coronavirus Disease-19 Pandemic
por: Khera, Rohan, et al.
Publicado: (2020)

Evaluation of the Anticipated Burden of COVID-19 on Hospital-Based Healthcare Services Across the United States
por: Khera, Rohan, et al.
Publicado: (2020)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2019)

Assessing the Compliance of Physicians With the American Diabetes Association (ADA) Guidelines in Prescribing Cardioprotective Antihyperglycemic Agents to Diabetic Patients at a University Hospital in Jeddah, Saudi Arabia
por: Sheikh, Ahmed M, et al.
Publicado: (2023)

Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act
por: Angraal, Suveen, et al.
Publicado: (2018)

Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
por: Munshi, Medha N., et al.
Publicado: (2022)

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
por: Lin, Shu Ning, et al.
Publicado: (2020)

Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States
por: Valero-Elizondo, Javier, et al.
Publicado: (2021)

Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016)

Proximal Predictors of Long-Term Discontinuance with Noninsulin Antihyperglycemic Agents
por: Stuart, Bruce C., et al.
Publicado: (2016)

HbA(1c) and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study
por: Lipska, Kasia J., et al.
Publicado: (2013)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Amla as an antihyperglycemic and hepato-renal protective agent in fluoride induced toxicity
por: Vasant, Rupal A., et al.
Publicado: (2012)

Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
por: Suaifan, Ghadeer A. R. Y., et al.
Publicado: (2015)

Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia
por: Krumholz, Harlan M., et al.
Publicado: (2016)

Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals
por: Sangi, Sibghatullah Muhammad Ali, et al.
Publicado: (2015)

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
por: Zhu, Wei, et al.
Publicado: (2019)

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
por: Khera, Rohan, et al.
Publicado: (2022)

Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
por: Phillips, Adam T., et al.
Publicado: (2017)

Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011
por: Bikdeli, Behnood, et al.
Publicado: (2017)

Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival
por: Yang, Daniel X., et al.
Publicado: (2021)

Metabolic effects of antihyperglycemic agents and mortality: meta-analysis of randomized controlled trials
por: Rados, Dimitris Varvaki, et al.
Publicado: (2020)

Selecting antihyperglycemic agents with proven safety: A must in COVID-19 era
por: Ghosal, Samit
Publicado: (2020)

Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults
por: Ding, Qinglan, et al.
Publicado: (2021)

Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT
por: Shahu, Andi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qge0m61ifmrku54697qhrerujb